Management of Acute Interstitial Pneumonitis in Young Children

Hospitalization and Initial Assessment

• Nasal flaring in a preschool‑aged child is a cardinal sign of respiratory distress and mandates inpatient evaluation and treatment. 1
• Immediate hospitalization with intravenous ampicillin or penicillin G is recommended for a 3‑year‑old presenting with fever, nasal flaring, and decreased appetite. 1
• Chest radiography should be obtained without delay to confirm the diagnosis and to delineate the pattern and extent of pulmonary involvement. 1

Empiric Antibiotic Therapy (Hospitalized Children < 5 years, Fully Immunized)

• First‑line therapy is intravenous ampicillin or penicillin G, targeting Streptococcus pneumoniae and other typical bacterial pathogens. 1
• Ceftriaxone or cefotaxime may be used as alternatives when local resistance patterns require broader coverage. 1
• Vancomycin should be added if there is high local penicillin resistance in invasive pneumococcal strains or if the child appears severely ill. 1

Coverage for Atypical Pathogens

• If clinical features suggest atypical pneumonia (gradual onset, prominent systemic symptoms), add azithromycin 10 mg/kg on day 1 followed by 5 mg/kg daily on days 2‑5. 1

Antiviral Considerations

• When influenza is suspected or confirmed (especially during flu season), start oseltamivir as soon as possible, ideally within 48 hours of symptom onset. 1
• Oseltamivir dosing for children 1‑9 years: 5‑8 mg/kg/day given as a single dose or divided into two doses, not exceeding 150 mg/day. 1
• Current CDC susceptibility data should be reviewed because antiviral resistance patterns vary seasonally. 1

Supportive Care Measures

• Provide adequate intravenous hydration when oral intake is limited by respiratory distress or poor appetite. 2
• Deliver supplemental oxygen to maintain peripheral oxygen saturation > 90‑92 %. 2
• Use antipyretics (acetaminophen or ibuprofen) for fever control and comfort. 2
• Continuously monitor respiratory rate, work of breathing, and oxygen requirements. 1

Monitoring and Reassessment

• Perform a mandatory clinical reassessment at 48‑72 hours to evaluate response to empiric therapy. 1
• If the child deteriorates or shows no improvement within this window, repeat chest imaging to look for complications (e.g., parapneumonic effusion) and obtain blood cultures if not already drawn. 1

Red‑Flag Indicators Requiring Escalation

• Worsening respiratory distress despite appropriate therapy. 2
• Persistent fever beyond 72 hours of antibiotic treatment. 2
• Development of pleuritic chest pain suggesting a parapneumonic effusion. 2
• Inability to maintain adequate oxygenation with supplemental oxygen alone. 1

Clinical Pitfalls to Avoid

• Do not attempt outpatient management when nasal flaring or other signs of respiratory distress are present; hospitalization is required. 1
• Do not withhold antibiotics in favor of “watchful waiting” in a child with respiratory distress and fever, as bacterial pneumonia can progress rapidly. 1
• Do not rely solely on chest radiography to differentiate bacterial from viral pneumonia; clinical judgment and therapeutic response are essential. 1
• Do not forget to consider influenza during the appropriate season; early antiviral therapy markedly improves outcomes. 1
• Do not delay empiric antibiotics while pursuing extensive work‑up for rare interstitial lung diseases; bacterial and viral causes are far more common in this age group. 1